Fintel reports that New Dimensions Trading has filed a 13G form with the SEC disclosing ownership of 1,370,000 shares of Orgenesis Inc (ORGS). This represents 5.36% of the company.

Orgenesis is a global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format at the point of care. The Orgenesis POCare Platform is comprised of three enabling components: a pipeline of licensedPOCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network.

Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. The POCare Network brings together patients, doctors, industry partners, research institutes and hospitals worldwide to achieve harmonized, regulated clinical development and production of the therapies.

What are other large shareholders doing?

 

Knoll Capital Management, LLC holds 1,316,364 shares representing 5.15% ownership of the company. No change in the last quarter.

Geode Capital Management, Llc holds 199,556 shares representing 0.78% ownership of the company. No change in the last quarter.

Ronit Capital LLP holds 54,167 shares representing 0.21% ownership of the company. No change in the last quarter.

Renaissance Technologies Llc holds 50,999 shares representing 0.20% ownership of the company. In it’s prior filing, the firm reported owning 56,299 shares, representing a decrease of 10.39%. The firm decreased its portfolio allocation in ORGS by 36.74% over the last quarter.

Northern Trust Corp holds 36,227 shares representing 0.14% ownership of the company. No change in the last quarter.

What is the overall Fund Sentiment?

There are 49 funds or institutions reporting positions in Orgenesis Inc. This is an increase of 2 owner(s) or 4.26%.

Average portfolio weight of all funds dedicated to Orgenesis Inc is 0.0241%, a decrease of 42.7341%. Total shares owned by institutions decreased in the last three months by 1.88% to 3,135,492 shares.

Fintel’s Fund Sentiment Score is a quantitative model that ranks companies from zero to 100 based on Fund Sentiment. Fund Sentiment is important because it tells you if funds are buying or selling – and in particular how the company ranks compared to other companies in the investing universe.

This article originally appeared on Fintel.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.